Back to dashboard
All PlansCoverageLow impact

Analysis of Proteomic Patterns for Early Detection of Cancer

Blue Cross & Blue Shield of Mississippi·MS · Oncology, OB-GYN, Urology +2 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This policy confirms that proteomic pattern analysis tests for early cancer detection (including ovarian and prostate cancer screening) remain classified as investigational and are not covered. The policy has not changed from previous versions and continues to exclude coverage for these tests.

Action Required

Action needed
No immediate action required. Continue to deny coverage for proteomic pattern analysis tests for cancer screening as they remain investigational. If providers request these tests, inform them they are not covered and would be patient responsibility.

Affected Billing Codes

84999

Related policy hubs